Trials / Completed
CompletedNCT02099929
Effects of Coffee Consumption on Glucose Metabolism
Coffee and Glucose Metabolism: Clinical, Crossover and Randomized Glucose Disposal Assay Using Stable Isotopes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Brasilia · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Epidemiological studies have shown an inverse association between coffee consumption and risk of type 2 diabetes mellitus (T2DM). However the experimental studies that analysed the mechanisms are limited. This project aims to assess the effects of coffee consumption on glucose metabolism, using stable isotope tracer (13C-glucose) to explain the possible metabolic mechanisms involved on the reduced risk for T2DM.
Detailed description
This is a crossover randomized clinical trial that has been studying 14 male healthy young adults, who were enrolled five treatments: coffee with sugar, coffee without sugar, decaffeinated coffee without sugar and two controls (water with and without sugar). The stable isotope minimal model protocol with oral glucose administration (Oral Dose Intravenous Label Experiment - ODILE) was performed. The use of ODILE methodology permits separation of the glucose absorbed and removed from the circulation increasing the accuracy and the effectiveness of glucose uptake and insulin sensitivity (Bluck et al., 2006).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Coffee with Sugar | 300mL of Coffee with 30g of Sugar |
| OTHER | Coffee without Sugar | 300mL of Coffee without Sugar |
| OTHER | Decaffeinated Coffee without Sugar | 300mL of Decaffeinated Coffee without Sugar |
| OTHER | Water with Sugar | 300mL of Water with 30g of Sugar |
| OTHER | Water without Sugar | 300mL of Water without Sugar |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2014-03-31
- Last updated
- 2014-03-31
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02099929. Inclusion in this directory is not an endorsement.